Issue 2/2012
Content (18 Articles)
Hereditary medullary thyroid carcinoma: the management dilemma
Ping Zhou, Jian Liu, Shao-Wen Cheng, Bing Wang, Rong Yang, Ling Peng
Management of duodenal adenomatosis in FAP: single centre experience
Musa Drini, Anthony Speer, Christopher Dow, Neil Collier, Prithi Bhathal, Finlay A. Macrae
Preimplantation genetic diagnosis for inherited breast cancer: first clinical application and live birth in Spain
Teresa Ramón y Cajal, Ana Polo, Olga Martínez, Carles Giménez, César Arjona, Gemma Llort, Lluís Bassas, Pere Viscasillas, Joaquin Calaf
Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families
S. M. Schneegans, A. Rosenberger, U. Engel, M. Sander, G. Emons, M. Shoukier
A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad
Ricardo Celestino, Jorge Lima, Alexandra Faustino, Valdemar Máximo, António Gouveia, João Vinagre, Paula Soares, José Manuel Lopes
Urologists’ and GPs’ knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands
Ruben Cremers, Christi van Asperen, Paul Kil, Hans Vasen, Tjerk Wiersma, Inge van Oort, Lambertus Kiemeney
Analysis of the miR-34a locus in 62 patients with familial cutaneous melanoma negative for CDKN2A/CDK4 screening
Angela M. Cozzolino, Lucia Pedace, Marco Castori, Paola De Simone, Nicoletta Preziosi, Isabella Sperduti, Chiara Panetta, Valerio Mogini, Carmelilia De Bernardo, Aldo Morrone, Caterina Catricalà, Paola Grammatico
Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months
Jin Zhang, Jia-Hua Pan, Bai-Jun Dong, Wei Xue, Dong-ming Liu, Yi-Ran Huang
Looking different, feeling different: women’s reactions to risk-reducing breast and ovarian surgery
Nina Hallowell, Brandi Baylock, Louise Heiniger, Phyllis N. Butow, Deepa Patel, Bettina Meiser, Christobel Saunders, Melanie A. Price
RB1 mutations and second primary malignancies after hereditary retinoblastoma
Charlotte J. Dommering, Tamara Marees, Annemarie H. van der Hout, Saskia M. Imhof, Hanne Meijers-Heijboer, Peter J. Ringens, Flora E. van Leeuwen, Annette C. Moll
Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
A. Moran, C. O’Hara, S. Khan, L. Shack, E. Woodward, E. R. Maher, F. Lalloo, D. G. R. Evans
The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer
Yael Laitman, Liron Herskovitz, Talia Golan, Bella Kaufman, Shani Shimon Paluch, Eitan Friedman
Can a gastrointestinal pathologist identify microsatellite instability in colorectal cancer with reproducibility and a high degree of specificity?
Eli Brazowski, Paul Rozen, Sara Pel, Ziona Samuel, Irit Solar, Guy Rosner
Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist’s initiative
K. M. Landsbergen, J. B. Prins, H. G. Brunner, P. van Duijvendijk, F. M. Nagengast, J. H. van Krieken, M. Ligtenberg, N. Hoogerbrugge
French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing
C. Maheu, T. Apostolidis, A. Petri-Cal, E. Mouret-Fourme, M. Gauthier-Villars, C. Lasset, P. Berthet, J.-P. Fricker, O. Caron, E. Luporsi, L. Gladieff, C. Noguès, C. Julian-Reynier
Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary non-polyposis colorectal cancer in Singapore
Vivian Wei Wang, Poh Koon Koh, Wai Leng Chow, Jeremy Fung Yen Lim
Families’ experience of oncogenetic counselling: accounts from a heterogeneous hereditary cancer risk population
Álvaro Mendes, Liliana Sousa
Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients
Muhammad U. Rashid, Sidra Gull, Kashif Asghar, Noor Muhammad, Asim Amin, Ute Hamann